Biodesix, Inc. (BDSX) Stock
Healthcare · Diagnostics & Research · Member of Other US Stocks
Biodesix, Inc. (BDSX) closed at USD 23.99 on 2026-10-14, a change of +266.3 % over the past year, with a market capitalization of USD 260.72M.
Biodesix, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 23.99 |
| 2026-10-13 | 25.00 |
| 2026-10-12 | 25.70 |
| 2026-10-09 | 26.02 |
| 2026-10-08 | 25.63 |
| 2026-10-07 | 26.42 |
| 2026-10-06 | 27.96 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Biodesix, Inc. key figures
- Previous close
- USD 23.99 (2026-10-14)
- 1-year change
- +266.3 %
- Market cap
- USD 260.72M
- Enterprise value
- USD 302.52M
- P/E ratio (trailing)
- -7.97
- P/E ratio (forward)
- -112.32
- EPS (trailing)
- -3.10
- EPS (forward)
- -0.22
- PEG ratio
- n/a
- Price to book
- 28.50
- Revenue growth
- 34.2 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 2.26
- Employees
- 334
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Biodesix, Inc.
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Biodesix, Inc. and compare it with other stocks.
Analyze BDSXAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Biodesix, Inc. shares.